Dermata Therapeutics, Inc.
DRMA
$1.18
-$0.04-3.28%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.75% | -45.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.86% | -9.99% | |||
| Operating Income | -11.86% | 9.99% | |||
| Income Before Tax | -12.16% | 9.74% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.16% | 9.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.16% | 9.74% | |||
| EBIT | -11.86% | 9.99% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 51.19% | 40.76% | |||
| Normalized Basic EPS | 51.19% | 40.76% | |||
| EPS Diluted | 51.19% | 40.76% | |||
| Normalized Diluted EPS | 51.19% | 40.76% | |||
| Average Basic Shares Outstanding | 129.78% | 52.35% | |||
| Average Diluted Shares Outstanding | 129.78% | 52.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
